Kynurenine and uric acid levels in chronic myeloid leukemia patients. - Wikidata - awgldk - TriplyDB

Kynurenine and uric acid levels in chronic myeloid leukemia patients.

Kynurenine and uric acid levels in chronic myeloid leukemia patients.

http://www.wikidata.org/entity/Q35507380

about

Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.Predictive and prognostic role of serum neopterin and tryptophan breakdown in prostate cancer Targeting Leukemia Stem Cells in the Bone Marrow Niche.

P2860

Q37079141-6E72002F-6D6D-4092-B355-49B77B4CD19C Q42216809-F49CDD44-BCAF-42E9-AD80-0D8AD6688E7C Q52375473-195ABC09-A915-4C59-8E49-FDD18BD9E165

P2860

Kynurenine and uric acid levels in chronic myeloid leukemia patients.

http://www.wikidata.org/entity/Q35507380

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Kynurenine and uric acid levels in chronic myeloid leukemia patients.

@ast

Kynurenine and uric acid levels in chronic myeloid leukemia patients.

@en

type

label

Kynurenine and uric acid levels in chronic myeloid leukemia patients.

@ast

Kynurenine and uric acid levels in chronic myeloid leukemia patients.

@en

prefLabel

Kynurenine and uric acid levels in chronic myeloid leukemia patients.

@ast

Kynurenine and uric acid levels in chronic myeloid leukemia patients.

@en

P1433

Q35507380-9DCC5C8C-D0FA-4599-A166-213C810B7598

P1476

Q35507380-47FB2FD1-AFC5-40EF-A711-7B53C12625E8

P2093

Q35507380-42A250CB-6A93-4818-9C9B-D9BB0E50D78B

Q35507380-675DBA9A-C333-4397-8874-336941767182

Q35507380-6FC5A21C-6E29-4D18-AB16-10C78367734A

Q35507380-78F1132A-BF50-4265-AD63-89D85B98A511

Q35507380-7F21EF59-6EBC-48CD-8394-7F9C10BBA6F6

Q35507380-8946D335-D105-4C37-A9B1-250D26FAE274

Q35507380-895B4074-3745-47E7-9EBE-9133643779F4

Q35507380-9D37820E-C782-4432-8B2A-9704B085A430

P2860

Q35507380-03F88B9B-F93C-436C-9648-BFAF3A54451B

Q35507380-0439F3D1-04AF-44E1-B0A6-C1F4667144DA

Q35507380-08D066A5-D61D-46FE-A31B-F7A87D4482E2

Q35507380-0B0B51F3-D060-45C7-93E7-01D450FCCE9F

Q35507380-0DB4E793-D9DB-4007-B52D-AF5316B17C91

Q35507380-16EF0E37-F261-4B58-861B-6214D7E91F15

Q35507380-19A0C619-22C9-4A25-AA4B-3D962563373B

Q35507380-340A6986-4B2D-4BED-90A6-3687ABE87979

Q35507380-3BC941D9-51CD-430A-AAE6-9F2BCBDC4365

Q35507380-41921143-BB54-4C90-B696-3E4C5D2F49A8

P304

Q35507380-873D41E3-72F0-44C6-983D-22463F3AA745

P31

Q35507380-2CF2282C-34E4-40C3-9447-6A665D5D16AB

P356

Q35507380-8D65C920-BFBB-4B8C-AE89-35E9244ADA7B

P433

Q35507380-08FB4149-953F-42A5-98B8-101B2420BE36

P478

Q35507380-B8C270AB-9E22-493D-B17E-F7366ACE5ABD

P50

Q35507380-E5D5512D-C54C-4FA4-92A3-B9829F14822D

P577

Q35507380-C6991A6A-B919-40D9-95DE-F420DA0A03DA

P698

Q35507380-3474D7AE-38CD-4A55-ACA3-F3159D55BBD7

P921

Q35507380-6894EADD-9012-459F-86AC-30A2DBEA447C

P932

Q35507380-61148AAB-3886-4772-9D9D-B6EBF14353FB

P356

2162402X.2014.992646

P1433

P1476

Kynurenine and uric acid levels in chronic myeloid leukemia patients

@en

P2093

Eva Hamsikova

http://www.w3.org/2001/XMLSchema#string

Hana Klamova

http://www.w3.org/2001/XMLSchema#string

Martina Duskova

http://www.w3.org/2001/XMLSchema#string

Martina Petrackova

http://www.w3.org/2001/XMLSchema#string

Monika Krmencikova-Fliegl

http://www.w3.org/2001/XMLSchema#string

Vladimir Vonka

http://www.w3.org/2001/XMLSchema#string

Zdenek Roth

http://www.w3.org/2001/XMLSchema#string

Zuzana Humlova

http://www.w3.org/2001/XMLSchema#string

P2860

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

Prevention of allogeneic fetal rejection by tryptophan catabolism

Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase

Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase

Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma

Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study

Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid-responsive elements.

Vascular endothelial expression of indoleamine 2,3-dioxygenase 1 forms a positive gradient towards the feto-maternal interface.

An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells.

Aging and proinflammatory cytokines.

P304

e992646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/2162402X.2014.992646

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Lenka Kujovska Krcmova

P577

2015-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25949913

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

4404910

http://www.w3.org/2001/XMLSchema#string